• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Hygienic Packaging Technology

    Trends in Solid Oral Dosage Delivery

    5 Reasons Paper Has No Place in Contract Manufacturing

    Injectable Drug Delivery Trends

    Pharmaceutical Manufacturing Equipment Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Jubilant Therapeutics Appoints Chief Scientific Officer

    Iontas and Fair Journey Biologics Partner with Quell Therapeutics

    Vetter Establishes Office in China

    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Vetter Establishes Office in China

    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

    Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Reed-Lane Facility Virtual Tour

    Hygienic Packaging Technology

    Reshaping the Pharmaceutical Supply Chain

    Serialization: Level 5 Solution

    Covectra Introduces Next-Gen Serialization Solution
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Vetter Establishes Office in China

    Data Management Trends

    AGC Biologics Expands Cell and Gene Facility in Italy

    Celonic to Boost Cell & Gene Therapy Production

    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Guide to Maintaining Validation of Older Facilities: Why, When and How

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Top BioPharma Form Accumulus Synergy

    Global Biosciences Co. Selects ValGenesis VLMS

    Gene Therapy Co. Selects ValGenesis' SaaS Platform
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Alcami

    Aphena Pharma Solutions

    Baxter BioPharma Solutions

    PCI Pharma Services

    Syngene
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Syngene

    Aphena Pharma Solutions

    Baxter BioPharma Solutions

    Almac Group

    Reed-Lane
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Sierra’s Momelotinib Granted FDA Fast Track Designation

    Underscores potential for momelotinib to address unmet needs of patients with Intermediate/High-Risk myelofibrosis who have previously received a JAK inhibitor

    Related CONTENT
    • Mogene
    • Avomeen Appoints Head of Elemental Analysis
    • Risk-Based Monitoring
    • FDA Approves Roche's Kadcyla for HER2-Positive Early Breast Cancer
    • Aclaris Therapeutics Submits IND for RA Treatment
    06.19.19
    Sierra Oncology, Inc. (SRRA) announced that the U.S. FDA has granted Fast Track designation to momelotinib, a JAK1, JAK2 and ACVR1 inhibitor, for the treatment of patients with intermediate/high-risk myelofibrosis who have previously received a JAK inhibitor.
     
    "Fast Track designation for momelotinib highlights the serious and significant unmet needs of patients with myelofibrosis who have previously received a JAK inhibitor. These patients typically suffer from uncontrolled constitutional symptoms, progressively worsening anemia often resulting in transfusion dependency, and enlarged spleens. Fast Track also recognizes the absence of FDA-approved treatments for these patients and that momelotinib has the potential to address their unmet needs," said Dr. Barbara Klencke, Chief Development Officer of Sierra Oncology. "We look forward to continuing to work closely with the FDA as we launch and conduct the MOMENTUM Phase 3 trial of momelotinib, with the goal of bringing this important therapy to patients expeditiously."
     
    "We are very pleased that momelotinib has been granted Fast Track designation by the FDA, which further reflects the collaborative and constructive dialogue we have had with the Agency concerning  the advancement of momelotinib towards potential registration," said Dr. Nick Glover, President & CEO of Sierra Oncology. 
    Related Searches
    • fast track
    • patients
    • fda
    • Development
    Suggested For You
    Mogene Mogene
    Avomeen Appoints Head of Elemental Analysis Avomeen Appoints Head of Elemental Analysis
    Risk-Based Monitoring Risk-Based Monitoring
    FDA Approves Roche FDA Approves Roche's Kadcyla for HER2-Positive Early Breast Cancer
    Aclaris Therapeutics Submits IND for RA Treatment Aclaris Therapeutics Submits IND for RA Treatment
    Intensity Therapeutics Receives FTD for Breast Cancer Treatment Intensity Therapeutics Receives FTD for Breast Cancer Treatment
    The Orphan Promise The Orphan Promise
    CytoDyn Evaluates Leronlimab for Triple-Negative Breast Cancer CytoDyn Evaluates Leronlimab for Triple-Negative Breast Cancer
    Cellectar Gains FDA Fast Track for CLR 131 in MM Cellectar Gains FDA Fast Track for CLR 131 in MM
    Lilly Lilly's CYRAMZA Gains Fifth Indication
    Swissfillon Completes Successful FDA Inspection Swissfillon Completes Successful FDA Inspection
    Dalton Pharma Services Completes PAI Inspection Dalton Pharma Services Completes PAI Inspection
    Eisai, Purdue Pharma Amend Lemborexant Alliance Eisai, Purdue Pharma Amend Lemborexant Alliance
    KASA to Support Generic Drug Review KASA to Support Generic Drug Review
    Are We Embracing FDA’s Messages? Are We Embracing FDA’s Messages?

    Related Breaking News

    • Promotions & Moves
      Jubilant Therapeutics Appoints Chief Scientific Officer

      Jubilant Therapeutics Appoints Chief Scientific Officer

      Luca Rastelli brings more than 20 years of oncology drug discovery and development experience.
      Kristin Brooks 03.08.21

    • Breaking News | Collaborations & Alliances
      Iontas and Fair Journey Biologics Partner with Quell Therapeutics

      Iontas and Fair Journey Biologics Partner with Quell Therapeutics

      Novel target binders from Iontas/FJB will be used to uncover functional antibodies to advance Quell’s engineered Treg cell therapy pipeline.
      Charles Sternberg, Assistant Editor 03.08.21

    • Breaking News | cGMP Manufacture | Drug Development | Industry News
      Vetter Establishes Office in China

      Vetter Establishes Office in China

      Additional office in Asia Pacific region to promote development of new business in China.
      Kristin Brooks 03.08.21


    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      AGC Biologics Expands Cell and Gene Facility in Italy

      AGC Biologics Expands Cell and Gene Facility in Italy

      Plans call for increased capacities and viral vector suspension capabilities at Milan site.
      Tim Wright, Editor, Contract Pharma 03.05.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      Celonic to Boost Cell & Gene Therapy Production

      Celonic to Boost Cell & Gene Therapy Production

      Will establish a new facility in the upcoming Life Science Park Rheintal in Stein, Switzerland.
      Tim Wright, Editor, Contract Pharma 03.05.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

      Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

      Continues to build integrated capabilities platform for cell and gene therapy.
      Tim Wright, Editor, Contract Pharma 03.05.21


    • Breaking News | Collaborations & Alliances | Drug Delivery | Industry News
      Aptamer Extends Collaboration with AstraZeneca

      Aptamer Extends Collaboration with AstraZeneca

      Will continue to explore next-generation drug delivery approaches.
      Tim Wright, Editor, Contract Pharma 03.05.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark

      Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark

      Virtual ground-breaking ceremony celebrates initiation of expansion to double cell culture capacity and add large scale fill/finish capabilities.
      Tim Wright, Editor, Contract Pharma 03.05.21

    • Breaking News | Industry News
      Amgen to Acquire Five Prime Therapeutics for $1.9B

      Amgen to Acquire Five Prime Therapeutics for $1.9B

      Adds Five Prime's pipeline of immuno-oncology and targeted cancer therapies to Amgen's oncology portfolio.
      Kristin Brooks 03.04.21


    • Bioanalytical Services | Breaking News
      Genesis Drug Discovery & Development Acquires Integrated Analytical Solutions

      Genesis Drug Discovery & Development Acquires Integrated Analytical Solutions

      Adds ‘off the shelf’ PK profiling capabilities to its portfolio.
      Charles Sternberg, Assistant Editor 03.04.21

    • Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer
      CureVac, Novartis Ink COVID Vax Mfg. Pact

      CureVac, Novartis Ink COVID Vax Mfg. Pact

      Novartis to manufacture the mRNA and bulk drug product of the CVnCoV vaccine for up to 50 million doses by the end of 2021.
      Kristin Brooks 03.04.21

    • Bio News | Breaking News | Collaborations & Alliances | CRO News | Drug Development | Drug Discovery | Industry News | R&D
      Innoforce and dMed Enter Development Collaboration

      Innoforce and dMed Enter Development Collaboration

      Aims to accelerate the development of innovative therapeutics.
      Tim Wright, Editor, Contract Pharma 03.03.21


    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site

      Matica Biotechnology Breaks Ground on Cell and Gene Therapy Site

      New 25,000 sq. ft. GMP facility located College Station, TX.
      Tim Wright, Editor, Contract Pharma 03.03.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | Promotions & Moves
      Four Female Leaders Appointed to Cell & Gene CDMO

      Four Female Leaders Appointed to Cell & Gene CDMO

      The Center for Breakthrough Medicines makes leadership appointments to fuel company growth.
      Tim Wright, Editor, Contract Pharma 03.03.21

    • Breaking News
      Fusion Pharmaceuticals Acquires IPN-1087

      Fusion Pharmaceuticals Acquires IPN-1087

      Expands its pipeline of potent alpha-emitting radiopharmaceuticals.
      Charles Sternberg, Assistant Editor 03.02.21

    Trending
    • Baxter Biopharma Solutions Enters Sterile Manufacturing Agreement For Novavax’ COVID-19 Vaccine
    • Four Female Leaders Appointed To Cell & Gene CDMO
    • Pharmaron Acquires Biomanufacturing Site In The UK From AbbVie
    Breaking News
    • Jubilant Therapeutics Appoints Chief Scientific Officer
    • Iontas and Fair Journey Biologics Partner with Quell Therapeutics
    • Vetter Establishes Office in China
    • AGC Biologics Expands Cell and Gene Facility in Italy
    • Celonic to Boost Cell & Gene Therapy Production
    View Breaking News >
    CURRENT ISSUE

    March 2021

    • Hygienic Packaging Technology
    • Trends in Solid Oral Dosage Delivery
    • 5 Reasons Paper Has No Place in Contract Manufacturing
    • Injectable Drug Delivery Trends
    • Pharmaceutical Manufacturing Equipment Trends
    • Oral Solids: Market & Technology Trends
    • Nutraceutical Manufacturing: Meeting the Challenges of Today, Planning for Tomorrow
    • 2021 Contract Manufacturing Survey
    • Small Molecule Development Trends
    • Challenges & Opportunities Facing Small & Emerging Biopharma Companies
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Diets High In Fructose Could Cause Immune System Damage
    Nestlé Acquires Premium Water Brand Essentia
    Kaneka Probiotics Announces Launch of L. plantarum DR7
    Coatings World

    Latest Breaking News From Coatings World

    Sherwin-Williams Announces Resignation of President, COO
    Ashland Completes Expansion, Relocation of Viatel Bioresorbable Polymers Manufacturing Facility
    Evonik Receives Sustainability Award from EcoVadis
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs First OTC Home Molecular COVID-19 Test
    FDA Approves Second Sight's Argus 2s Retinal Prosthesis
    Cross Border Venture Financing Rose in Final Quarter of 2020
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Sharp Appoints EU Qualified Person
    Baxter Biopharma Solutions Enters Sterile Manufacturing Agreement for Novavax’ COVID-19 Vaccine
    Metrics Contract Services Completes Russian Regulatory Inspection
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    It's International Women's Day—But What Does That Mean?
    e.l.f. Cosmetics and Chipotle Collaborate on Burrito-Inspired Makeup Collection
    Weekly Recap: Sephora Expansion, Ulta Partners with Loop, International Women’s Day & More
    Happi

    Latest Breaking News From Happi

    Cococare Appoints First Woman President
    Ross Highlights Triple Shaft Mixers
    Arm & Hammer Unveils Foot Wipes
    Ink World

    Latest Breaking News From Ink World

    Capital Printing Invests in 2nd Komori Press
    Arna Marketing Adds Canon’s ProStream, VarioPRINT iX Production Inkjet Presses
    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Xeikon details upcoming Xeikon Café TV seminars
    Resource Label Group acquires New England Label
    UV+EB-cured products rated 'easier to recycle'
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Arm & Hammer Launches Foot Wipes
    Kimberly-Clark Names Chief Research and Development Officer
    FPInnovations Develops Biodegradable Mask
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Australia Clears Conformis' iTotal PS Knee Replacement System
    Colfax Decides to Divide Its Businesses
    Stryker Corp.'s 2020 Sales Slip 3.6 Percent
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research
    Wearable Patch Market to Reach $27.8 Billion by 2027: Allied Market Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login